Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBIOX vs. FBTAX: which is better?

Bottom line

FBIOX vs FBTAX: the short answer

FBIOX (Biotechnology Portfolio) and FBTAX (Fidelity Advisor Biotechnology Fund) share a meaningful slice of their top holdings — about 52% by weight.

FBIOX is cheaper at 0.62% vs 0.94% — a difference of $32 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs +3.5% for FBIOX (reporting dates differ).

Updated Nov 19, 2026

FBIOX vs FBTAX side by side

FBIOXFBTAX
TypeMutual fundMutual fund
Fund familyFidelityFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.62%0.94%
Annual cost per $10k$62$94
10-yr cost on $10k (prospectus)$774$1,663
Max front load——
12b-1 fee0%0.25%
1-yr return+36.4%+31.5%
5-yr return (annualized)+3.5%+6.4%
10-yr return (annualized)+6.9%+7.7%
Best quarter+33.6%+30.3%
Worst quarter−28.4%−27.8%
Net assets (fund)$5.3B$2.2B
Number of holdings215129
Portfolio turnover45%54%
Returns as ofApr 30, 2026Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBIOXFBTAXDifference
2025+36.4%+39.6%−3.2%
2024+7.3%+5.3%+1.9%
2023+10.1%+10.7%−0.6%
2022−15.9%−8.0%−7.9%
2021−12.4%−3.6%−8.8%
2020+38.3%+32.2%+6.2%
2019+36.0%+25.7%+10.3%
2018−10.7%−3.8%−7.0%
2017+27.9%+25.8%+2.1%
2016−23.7%−23.6%−0.1%

Source: Fund prospectus bar charts

Holdings overlap

13 of FBIOX's top 25 holdings also appear in FBTAX's top 25.

Shared top holdings
HoldingFBIOXFBTAX
Abbvie Inc9.22%14.71%
Amgen Inc6.53%2.37%
Gilead Sciences Inc4.82%5.70%
Fidelity Revere Street Trust3.35%1.96%
Alnylam Pharmaceuticals Inc2.93%3.62%
Insmed Inc2.25%3.05%
Argenx Se2.25%3.00%
Ascendis Pharma A/s2.04%2.99%
Revolution Medicines Inc2.02%3.00%
Natera Inc1.41%1.43%
Moderna Inc1.28%1.60%
Biogen Inc1.26%2.71%
Cogent Biosciences Inc1.07%3.25%

Source: SEC Form N-PORT

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

FAQ

What is the difference between FBIOX and FBTAX?
FBIOX (Biotechnology Portfolio) and FBTAX (Fidelity Advisor Biotechnology Fund) share a meaningful slice of their top holdings — about 52% by weight. FBIOX is cheaper at 0.62% vs 0.94% — a difference of $32 a year per $10,000 invested.
Which is cheaper, FBIOX or FBTAX?
FBIOX has the lower expense ratio (0.62%).
Should I own both FBIOX and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.